Synaptics Incorporated: DCF model
A discounted-cash-flow model filled in from Synaptics Incorporated's filings as reported. Change any assumption; the values follow at once.
A tool for your own analysis, not investment advice. It does arithmetic on the figures the company filed and on assumptions you choose; it does not forecast, and the result is only as good as those assumptions. Every formula is on the methodology page.
Market price USD 118.50 on Oct 29, 2026: Closing price the SEC publishes with its fails-to-deliver data (SYNA).
Assumptions: Base case
Change any figure; the values follow at once.
Revenue and margins
From the filings10-K filed Aug 10, 2026
The years between change on a straight line.
From the filingsThe first year starts at Revenue growth a year from FY2022 to FY2025 (3 years): -4.05% a year; the years after are your assumption.
The years between change on a straight line.
From the filingsAverage operating margin, FY2023–FY2025: -8.32%; the years ahead are your assumption.
Tax and reinvestment
Your assumptionThe effective rate cannot be worked out (losses or no tax line): 25% to start with.
From the filingsAverage share of revenue, FY2023
From the filingsAverage share of revenue, FY2023–FY2025
From the filingsAverage operating working capital (current assets less cash and short-term investments, less current liabilities other than debt) as a share of revenue, FY2023–FY2025
Discount rate
Your assumption1.0 to start with
Your assumption5% to start with
From the filingsInterest expense of FY2025 over its average debt, held between the risk-free rate and 8 points above it
From the filingsDebt over debt plus market value on Oct 29, 2026
After the last year
Your assumption2.5% to start with.
From value to shares (every case)
Balance sheet of Q1FY2026, Sep 26, 2026 · 10-Q filed Nov 5, 2026
From the filings
From the filings
From the filings
From the filings
Your assumption
From the filingsdiluted, weighted average, Q1FY2026 · 10-Q filed Nov 5, 2026
The three cases
Base case: value per share
Discount rate 9.20%; long-run growth 2.50%. Values as at the end of FY2025.
| Present value of the 5 projected years | −USD 381 M |
|---|---|
| Present value after the last year | −USD 1.0 B |
| Enterprise value (the whole business) | −USD 1.4 B |
| Less debt | USD 838 M |
| Plus cash and short-term investments | USD 368 M |
| Equity value (the shareholders') | −USD 1.9 B |
| Divided by shares (millions) | 39.4 |
| Value per share | USD -47.03 |
Value per share
USD -47.03
Below zero: with these figures the debt is worth more than the business.
Price USD 118.50 on Oct 29, 2026
Base case: year by year
Millions of USD. The FY2025 column is as reported; the years after are projected. Tax, capital spending and working capital are signed as they add to (+) or take from (−) free cash flow.
| USD millions | FY2025reported | FY2026projected | FY2027projected | FY2028projected | FY2029projected | FY2030projected |
|---|---|---|---|---|---|---|
| Revenue | 1,197 | 1,149 | 1,121 | 1,112 | 1,122 | 1,150 |
| Growth | 11.4% | -4.0% | -2.4% | -0.8% | 0.9% | 2.5% |
| Operating income (EBIT) | −67 | −96 | −93 | −93 | −93 | −96 |
| Operating margin | -5.6% | -8.3% | -8.3% | -8.3% | -8.3% | -8.3% |
| Tax on operating income | −0 | −0 | −0 | −0 | −0 | |
| Depreciation and amortisation | — | 33 | 32 | 32 | 32 | 33 |
| Capital spending | −48 | −38 | −37 | −37 | −37 | −38 |
| Change in working capital | 1.8 | 1 | 0.3 | −0.4 | −1 | |
| Free cash flow to the firm | −169 | −99 | −97 | −97 | −99 | −102 |
| Discount factor | 0.9158 | 0.8386 | 0.7679 | 0.7033 | 0.6440 | |
| Present value | −90 | −81 | −75 | −69 | −65 |
Base case: sensitivity
How the value per share moves when one pair of figures changes and the rest stay as they are.
Discount rate and long-run growth
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Discount rate ↓ · Long-run growth → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.20% | -54.59 | -57.88 | -61.88 | -66.83 | -73.11 |
| 8.20% | -48.22 | -50.49 | -53.15 | -56.33 | -60.18 |
| 9.20% | -43.51 | -45.15 | -47.03 | -49.21 | -51.78 |
| 10.20% | -39.88 | -41.11 | -42.5 | -44.07 | -45.89 |
| 11.20% | -37 | -37.95 | -39 | -40.19 | -41.52 |
Revenue growth and operating margin
Value per share in USD; your figures in the outlined middle; green at or above the market price, red below it.
| Growth, every year ↓ · Margin, every year → | −4 pt | −2 pt | ±0 pt | +2 pt | +4 pt |
|---|---|---|---|---|---|
| −4 pt | -54.06 | -47.4 | -40.74 | -34.08 | -27.42 |
| −2 pt | -58.34 | -51.05 | -43.75 | -36.46 | -29.17 |
| ±0 pt | -62.97 | -55 | -47.03 | -39.06 | -31.08 |
| +2 pt | -67.99 | -59.29 | -50.58 | -41.87 | -33.16 |
| +4 pt | -73.42 | -63.92 | -54.42 | -44.92 | -35.42 |
Where the figures come from
The statements as reported, in millions of USD; hover a figure for its filing.
| USD millions | FY2025to Jun 27, 2026 | FY2024to Jun 28, 2025 | FY2023to Jun 29, 2024 | FY2022to Jun 24, 2023 | FY2021to Jun 25, 2022 | FY2020to Jun 26, 2021 |
|---|---|---|---|---|---|---|
| Revenue | 1,197 | 1,074 | 959 | 1,355 | 1,740 | 1,340 |
| Growth | 11.4% | 12.0% | -29.2% | -22.1% | 29.9% | — |
| Operating income | −67 | −94 | −102 | 154 | 350 | 147 |
| Operating margin | -5.6% | -8.8% | -10.6% | 11.4% | 20.1% | 11.0% |
| Effective tax rate | — | — | — | 41.6% | 20.2% | 26.1% |
| D&A, % of revenue | — | — | 2.9% | 2.0% | 1.4% | 1.6% |
| Capital spending, % of revenue | 4.0% | 2.4% | 3.5% | 2.5% | 1.8% | 1.6% |
| Working capital, % of revenue | 6.9% | 2.7% | 1.5% | 6.2% | 4.0% | -33.1% |
| Free cash flow to the firm | −169 | −134 | −38 | 72 | −241 | — |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
- From the filings: revenue, margins, tax rate, depreciation, capital spending and working capital (fiscal years above), debt, cash, leases and minority interests (balance sheet of Q1FY2026), and the share count (Q1FY2026).
- Market data: US Treasury daily par yield curve, 10-year (Nov 13, 2026); Market price USD 118.50 on Oct 29, 2026: Closing price the SEC publishes with its fails-to-deliver data (SYNA).
- Your assumptions: the growth path and margins ahead, beta, the equity risk premium, long-run growth or the exit multiple, and the weights of the cases. How each figure is worked out: methodology.